Saccharolytic SCFAs (Acetate, Butyrate, Proprionate) Test

Acetate, propionate, and butyrate are short-chain fatty acids (SCFAs) produced by gut bacteria when they ferment dietary fibers, complex carbohydrates that escape digestion in the small intestine. This fermentation process, known as saccharolysis (from the Greek saccharo- for sugar), is one of the most important examples of symbiosis between humans and their microbiome. The resulting SCFAs serve as both local fuel for the colon and systemic signaling molecules that influence nearly every aspect of metabolism and inflammation.

In the colon, specific bacteria break down fibers like inulin, pectin, and resistant starch, yielding SCFAs in typical ratios of about 60% acetate, 20% propionate, and 20% butyrate. These ratios can shift depending on diet, microbial composition, and gut transit time. Acetate is the most abundant and diffuses easily into the bloodstream, where it can be used for energy or lipid synthesis. Propionate primarily travels to the liver, where it supports glucose production (a process called gluconeogenesis). Butyrate, on the other hand, stays mostly in the colon, where it serves as the main energy source for colonocytes (cells lining the large intestine), supports a healthy mucus barrier, and helps suppress inflammation.

Beyond energy metabolism, SCFAs have profound effects on gene expression and immune function. They activate G-protein-coupled receptors (GPR41 and GPR43), which influence gut motility, satiety, and immune balance. Butyrate and propionate also inhibit histone deacetylases (HDACs), enzymes that modify how tightly DNA is packaged in cells. This “epigenetic” mechanism allows SCFAs to regulate which genes are turned on or off, leading to benefits like reduced inflammation and improved insulin sensitivity.

Healthy SCFA production supports gut integrity, lowers the risk of inflammatory bowel diseases, and contributes to whole-body metabolic stability. But low SCFA levels, often due to low fiber intake, gut dysbiosis, or antibiotic use, can weaken the gut barrier and promote systemic inflammation, insulin resistance, and even neuroinflammatory changes linked to mood and cognition.

Conversely, excessive or imbalanced SCFA production may occur in certain dysbiotic states, potentially contributing to gas, bloating, or altered gut-brain signaling. The overall balance between saccharolytic (fiber-fermenting) and proteolytic (protein-fermenting) pathways in the gut reflects the health of the microbiome and its metabolic output.

By maintaining a fiber-rich diet, especially one that includes diverse fermentable fibers such as resistant starches and soluble fibers, you can promote the growth of SCFA-producing bacteria, helping stabilize metabolism, reduce inflammation, and enhance both gut and brain health over time.